| Cas No.: | 944396-07-0 |
| 名称: | 5-(2,6-dimorpholinopyrimidin-4-yl)-4-(trifluoromethyl)pyridin-2-amine |
| 别名: | NVP-BKM-120, BKM-120; Buparlisib |
| SMILES: | C(N)1=NC=C(C2C=C(N3CCOCC3)N=C(N3CCOCC3)N=2)C(C(F)(F)F)=C1 |
| 分子式: | C18H21F3N6O2 |
| 分子量: | 410.39 |
| 纯度: | |
| 保存条件: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | |
| In Vivo: | |
| In Vitro: | |
| References: | Buparlisib, also known as BKM120, is an orally bioavailable specific oral inhibitor of the pan-class I phosphatidylinositol 3-kinase (PI3K) family of lipid kinases with potential antineoplastic activity. PI3K inhibitor BKM120 specifically inhibits class |
| Kinase Assay: | |
| Cell Assay: | |
| Animal Administration: | |
| References: |
MSDS
COA
| LOT NO. | DOWNLOAD |
|
|
|
| 2018-0101 |
|
